Literature DB >> 8601403

Autocrine growth loop of the epidermal growth factor receptor in normal and immortalized human bronchial epithelial cells.

M S Tsao1, H Zhu, J Viallet.   

Abstract

Epidermal growth factor (EGF) is a potent growth factor for human normal bronchial epithelial (HBE) cells and lung cancer cells, which often demonstrate an EGF receptor (EGFR) autocrine loop. We have found that HBE cells are capable of proliferating in basal medium without EGF supplementation, and this suggests the probable presence of an active EGFR autocrine loop in non-neoplastic HBE cells. Northern blot hybridization shows that the parental and immortalized HBE cells express comparable and high levels of mRNA for EGFR, transforming growth factor-alpha (TGF-alpha), and amphiregulin (AR), but not EGF. Incubation with neutralizing monoclonal antibodies (mAb) against EGFR partially inhibits the growth of these cells. Immunohistochemistry shows that HBE cells express the TGF-alpha peptide in vitro and in vivo, however, neutralizing mAbs against TGF-alpha fail to inhibit their proliferation. In contrast, AR stimulates the growth of HBE cells. Thus, several EGF-family ligands appear to be involved functionally in the EGFR autocrine growth loop in HBE cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601403     DOI: 10.1006/excr.1996.0081

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection.

Authors:  Fiona H Blackhall; Melania Pintilie; Dennis A Wigle; Igor Jurisica; Ni Liu; Nikolina Radulovich; Michael R Johnston; Shaf Keshavjee; Ming-Sound Tsao
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

Review 2.  Role of epidermal growth factor receptor in lung cancer and targeted therapies.

Authors:  Tie-Cheng Liu; Xin Jin; Yan Wang; Ke Wang
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

3.  Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer.

Authors:  Andrea Baillo; Craig Giroux; Stephen P Ethier
Journal:  J Cell Physiol       Date:  2011-10       Impact factor: 6.384

Review 4.  Amphiregulin as a novel target for breast cancer therapy.

Authors:  Nicole E Willmarth; Stephen P Ethier
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-04-25       Impact factor: 2.673

5.  Integration of growth factor, extracellular matrix, and retinoid signals during bronchial epithelial cell differentiation.

Authors:  N Moghal; B G Neel
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

6.  Role of EGF receptor ligands in TCDD-induced EGFR down-regulation and cellular proliferation.

Authors:  Christina M Campion; Sandra Leon Carrion; Gayatri Mamidanna; Carrie Hayes Sutter; Thomas R Sutter; Judith A Cole
Journal:  Chem Biol Interact       Date:  2016-04-23       Impact factor: 5.192

7.  Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma.

Authors:  N Liu; T Furukawa; M Kobari; M S Tsao
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

8.  EGF-Amphiregulin Interplay in Airway Stem/Progenitor Cells Links the Pathogenesis of Smoking-Induced Lesions in the Human Airway Epithelium.

Authors:  Wu-Lin Zuo; Jing Yang; Kazunori Gomi; IonWa Chao; Ronald G Crystal; Renat Shaykhiev
Journal:  Stem Cells       Date:  2016-11-17       Impact factor: 6.277

9.  Etiologic Role of Kinases in the Progression of Human Cancers and Its Targeting Strategies.

Authors:  Sanjoy Das; Bireswar Bhattacharya; Biplajit Das; Bibek Sinha; Taison Jamatia; Kishan Paul
Journal:  Indian J Surg Oncol       Date:  2019-08-19

10.  Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.

Authors:  E S Clark; B Brown; A S Whigham; A Kochaishvili; W G Yarbrough; A M Weaver
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.